Low-dose methotrexate in the treatment of widespread morphea
- 1 August 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 39 (2) , 220-225
- https://doi.org/10.1016/s0190-9622(98)70079-9
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patientsBritish Journal of Dermatology, 1996
- METHOTREXATE ACTION IN RHEUMATOID ARTHRITIS: STIMULATION OF CYTOKINE INHIBITOR AND INHIBITION OF CHEMOKINE PRODUCTION BY PERIPHERAL BLOOD MONONUCLEAR CELLSRheumatology, 1995
- Increased spontaneous production of IL-8 in peripheral blood monocytes from the psoriatic patient: relation to focal infection and response to treatmentsJournal of Dermatological Science, 1995
- Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized sclerodermaArchives of Dermatological Research, 1995
- Treatment of localised scleroderma with PUVA bath photochemotherapyPublished by Elsevier ,1994
- Effects of methotrexate on glycosaminoglycan production by scleroderma fibroblasts in culture.Annals of the Rheumatic Diseases, 1993
- Use of a durometer to assess skin hardnessPublished by Elsevier ,1993
- Treatment of systemic sclerosis with γ-interferonBritish Journal of Dermatology, 1992
- The Pharmacology and Clinical Use of MethotrexateNew England Journal of Medicine, 1983
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976